Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fasting × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7 Gastrointestinal 6 Thoracic 5 Plasma cell 3 Lymphoid 3 CNS 3 Genitourinary 2 Other hematologic neoplasm 1 Other 1 Head & Neck 1 Gynecologic 1 Endocrine 1

Conditions

Ovarian Neoplasms 2758 Uterine Cervical Neoplasms 1871 Endometrial Neoplasms 1147 Fallopian Tube Neoplasms 707 Breast Neoplasms 703 Carcinoma, Ovarian Epithelial 676 Neoplasms 457 Colorectal Neoplasms 366 Carcinoma, Non-Small-Cell Lung 358 Uterine Cervical Dysplasia 318 Pancreatic Neoplasms 311 Stomach Neoplasms 303 Prostatic Neoplasms 270 Lung Neoplasms 266 Melanoma 247 Uterine Neoplasms 207 Vulvar Neoplasms 205 Peritoneal Neoplasms 203 Urinary Bladder Neoplasms 200 Esophageal Neoplasms 197 Neoplasm Metastasis 195 Head and Neck Neoplasms 191 Sarcoma 190 Papillomavirus Infections 180 Recurrence 178 Colonic Neoplasms 177 Carcinoma, Renal Cell 172 Triple Negative Breast Neoplasms 159 Squamous Cell Carcinoma of Head and Neck 153 Vaginal Neoplasms 129

Interventions

Diet, Vegan 1 Angptl4 protein, mouse 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03162289 2022-12-13

FIT2

Charite University, Berlin, Germany

Phase NA Unknown

BreastGynecologic

Breast Neoplasms, Fasting, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡